EGFR MUTATION-RELATED TUMORS

Clinical trials for EGFR MUTATION-RELATED TUMORS explained in plain language.

Never miss a new study

Get alerted when new EGFR MUTATION-RELATED TUMORS trials appear

Sign up with your email to follow new studies for EGFR MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New approach targets lung Cancer's genetic engine

Disease control Recruiting now

This early-stage trial is testing a new drug called BG-60366 in people with advanced non-small cell lung cancer that has a specific genetic change called an EGFR mutation. The drug is designed to find and break down the faulty protein that drives this type of cancer. Researchers …

Matched conditions: EGFR MUTATION-RELATED TUMORS

Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control

Last updated Apr 01, 2026 20:10 UTC

EGFR MUTATION-RELATED TUMORS

Get alerted when new EGFR MUTATION-RELATED TUMORS trials appear

New approach targets lung Cancer's genetic engine